A fixed-dose combination of isosorbide dinitrate and hydralazine (FDC-I/H) is associated with a substantial reduction in first and recurrent heart failure (HF) hospitalizations and in total all-cause hospitalizations.
It is advised that treatment for hypercholesterolemia begins prior to age 80, but if therapy is initiated after that, decisions must be made carefully due to a lack of high-quality empirical evidence.
It is difficult to assess whether the high rates of violent crimes among NFL players are due to repeated head injuries and brain damage, but it may be a contributing factor that merits attention and research.
Physicians are entrusted with providing care for their patients but are rarely counseled on their own mental health, particularly regarding suicide.
Exposure in the womb to household chemicals known as phthalates might increase a child's future risk of developing asthma.
A simple urine test can routinely spot human papillomavirus (HPV).
For patients with prostate cancer, combination beam plus brachytherapy does not compromise long-term sexual function compared with external beam radiotherapy (EBRT).
Including women >70 years of age in national breast cancer screening programs won't lead to a sharp reduction in advanced forms of the disease.
Although magnesium sulfate is routinely given to pregnant women at risk for very preterm delivery, new research suggests it won't provide any long-term benefits for infants.
A combination drug therapy of long-acting beta agonists and inhaled corticosteroids appears to be the best treatment for older adults with chronic obstructive pulmonary disease (COPD), especially those with asthma.